Kuniaki Kaga
Director/Board Member bei NXERA PHARMA CO., LTD.
Profil
Kuniaki Kaga ist Mitglied des Vorstands der Sosei Group Corp. In der Vergangenheit hatte er die Position des Executive Officer & GM-Healthcare Strategy bei Mitsubishi Chemical Holdings Corp. Präsident & Direktor bei The Kaiteki Institute, Inc. Representative Director & GM-Research Division bei Mitsubishi Tanabe Pharma Corp. und Executive Officer & GM-Healthcare Planning bei Mitsubishi Chemical Corp. (alt) (die alle Tochtergesellschaften der Mitsubishi Chemical Holdings Corp. sind). Er erhielt einen Bachelor-Abschluss von der Universität Tokio.
Aktive Positionen von Kuniaki Kaga
| Unternehmen | Position | Beginn |
|---|---|---|
| NXERA PHARMA CO., LTD. | Director/Board Member | 22.06.2018 |
| SUSMED,INC. | Director/Board Member | 01.01.2021 |
Ehemalige bekannte Positionen von Kuniaki Kaga
| Unternehmen | Position | Ende |
|---|---|---|
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | President | - |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Corporate Officer/Principal | - |
Mitsubishi Chemical Corp. (Old)
 Mitsubishi Chemical Corp. (Old) Chemicals: SpecialtyProcess Industries Mitsubishi Chemical Corp. engages in the manufacture and sale of pharmaceutical intermediates and ingredients. It develops, produces, and sells performance products, health care products, industrial materials, and other chemicals. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Compliance Officer | - |
Ausbildung von Kuniaki Kaga
| University of Tokyo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MITSUBISHI CHEMICAL GROUP CORPORATION | Process Industries |
| NXERA PHARMA CO., LTD. | Health Technology |
| SUSMED,INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Mitsubishi Chemical Corp. (Old)
Mitsubishi Chemical Corp. (Old) Chemicals: SpecialtyProcess Industries Mitsubishi Chemical Corp. engages in the manufacture and sale of pharmaceutical intermediates and ingredients. It develops, produces, and sells performance products, health care products, industrial materials, and other chemicals. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan. | Process Industries |
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
The Kaiteki Institute, Inc.
The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Commercial Services |
